Systemic sarcoidosis induced by etanercept: First brazilian case report;Sarcoidose sistêmica induzida por etanercepte: Primeiro relato de caso brasileiro

Anais Brasileiros de Dermatologia

Volumn 88, Issue 6 SUPPL.1, 2013, Pages 197-199

  Unterstell, Natasha ^a   Bressan, Aline Lopes ^a   Serpa, Laura Araújo ^a   da Castro, Pérola Peres Fonseca ^a   Gripp, Alexandre Carlos ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Diagnosis; Granuloma; Sarcoidosis; Tumor necrosis factor alpha

Indexed keywords

ETANERCEPT; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MIDDLE AGED; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SKIN CULTURE; SKIN DEFECT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRAZIL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOIDOSIS; SKIN DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890663020     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20132588     Document Type: Article

References (10)

1. Daldon PEC; Arruda LHF. Noninfectious granulomas: sarcoidosis. An Bras Dermatol. 2007;82:559-571.
2. Aguiar M, Marçal N, Mendes AC, Bugalho de Almeida A. Infliximab for treating sar-coidosis patients, Portuguese experience. Rev Port Pneumol. 2011;17:85-93.
3. Hostettler KE, Studler U, Tamm M, Brutsche MH. Long-term treatment with infliximab in patients with sarcoidosis. Respiration. 2012; 83:218-224.
4. Gifre L, Ruiz-Esquide V, Xaubet A, Gómez-Puerta JA, Hernández MV, Sanmartí R. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review. Arch Bronconeumol. 2011;47:208-212.
5. Fok KC, Ng WW, Henderson CJ, Connor SJ. Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab. J Crohns Colitis. 2012;6:708-712.
6. Cathcart S, Sami N, Elewski B. Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors. J Drugs Dermatol. 2012;11:609-612.
7. Lamrock E, Brown P. Development of cutaneous sarcoidosis during treatment with tumor necrosis alpha factor antagonists. Australas J Dermatol. 2012;53:e87-90.
8. Massara A, Cavazzini L, La Corte R, Trotta F. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new 'class effect' paradoxical phenomenon. Tw o case reports and literature review. Semin Arthritis Rheum. 2010;39:313-319.
9. Lukacs NW, Chensue SW, Strieter RM, Warmington K, Kunkel SL. Inflammatory gra-nuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecu-le-1. J Immunol. 1994;152:5883-5889.
10. Vigne C, Tebib JG, Pacheco Y, Coury F. Sarcoidosis: An underestimated and potentially severe side effect of anti-TNF-alpha therapy. Joint Bone Spine. 2013;80:104-107.